HomeInsightsStock Comparison

Divis Laboratories Ltd vs Laurus Labs Ltd Stock Comparison

Divis Laboratories Ltd vs Laurus Labs Ltd Stock Comparison

Last Updated on: May 07, 2025

Key Highlights

  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 6123 as of 07 May 09:33.
  • The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 56.9 on March 2024 . This represents a CAGR of 8.24% over 5 yearsThe P/E Ratio of Laurus Labs Ltd changed from 13.5 on March 2020 to 131.5 on March 2024 . This represents a CAGR of 57.66% over 5 years.
  • The Market Cap of Divis Laboratories Ltd changed from ₹ 52763 crore on March 2020 to ₹ 91234 crore on March 2024 . This represents a CAGR of 11.57% over 5 yearsThe Market Cap of Laurus Labs Ltd changed from ₹ 3449 crore on March 2020 to ₹ 21113 crore on March 2024 . This represents a CAGR of 43.67% over 5 years.
  • The revenue of Divis Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 2401 crore. This represent the decline of -100% The revenue of Laurus Labs Ltd for the Mar '25 is ₹ 1778 crore as compare to the Dec '24 revenue of ₹ 1424 crore. This represent the growth of 24.88%.
  • The ebitda of Divis Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 825 crore. This represent the decline of -100% The ebitda of Laurus Labs Ltd for the Mar '25 is ₹ 479.17 crore as compare to the Dec '24 ebitda of ₹ 294.57 crore. This represent the growth of 62.67%.
  • The net profit of Divis Laboratories Ltd changed from ₹ 356 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Laurus Labs Ltd changed from ₹ 28.4 crore to ₹ 233.87 crore over 8 quarters. This represents a CAGR of 186.96% .
  • The Dividend Payout of Divis Laboratories Ltd changed from 33.04 % on March 2020 to 50.44 % on March 2024 . This represents a CAGR of 8.83% over 5 yearsThe Dividend Payout of Laurus Labs Ltd changed from 10.13 % on March 2020 to 19.27 % on March 2024 . This represents a CAGR of 13.72% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

About Laurus Labs Ltd

  • Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology.
  • The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others.
  • The company currently operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh.
  • Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API. The company's strategic and early investments in R&D and manufacturing infrastructure has enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing 'donor-funded access-to-medicines markets' of Sub-Saharan Africa, South-East Asia and Latin America.

Divis Laboratories Ltd News Hub

News

Divis Lab spurts as broker maintains buy call

In its latest note, the broker highlighted Divi's strong potential to emerge as a primary ...

Read more

24 Apr 2025 13:45

News

Divis Labs jumps on signing long-term manufacturing pact with global pharma major

In a regulatory filing on 18 April 2025, Divi's stated that the agreement pertains to the ...

Read more

21 Apr 2025 10:18

News

Divis Laboratories enters into long term manufacturing and supply agreement

Divis Laboratories has signed a long term manufacturing and supply agreement with a global...

Read more

18 Apr 2025 10:02

News

Divi's Laboratories announces change in senior management

Divi's Laboratories announced that G. Bala Kishore, serving as General Manager (EHS) of th...

Read more

31 Mar 2025 10:14

News

Volumes jump at Divis Laboratories Ltd counter

IndusInd Bank Ltd, Axis Bank Ltd, Gujarat State Petronet Ltd, Kaynes Technology India Ltd ...

Read more

12 Mar 2025 11:00

News

Divis Laboratories Ltd spurts 2.08%, up for third straight session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

13 Feb 2025 13:05

Laurus Labs Ltd News Hub

News

Board of Laurus Labs recommends 2nd interim dividend

Laurus Labs announced that the Board of Directors of the Company at its meeting held on 24...

Read more

24 Apr 2025 16:52

News

Laurus Lab Q4 PAT soars to Rs 234 cr

Revenue from operations jumped 19.49% YoY to Rs 1,720.30 crore in Q4 FY25. Profit before t...

Read more

24 Apr 2025 17:20

News

Laurus Labs declare Quarterly Result

Laurus Labs will hold a meeting of the Board of Directors of the Company on 24 April 2025....

Read more

11 Apr 2025 09:55

News

Laurus Labs to acquire 26% stakes in Kurnool Renewables for Rs 35 cr

The strategic move will enable Laurus Labs to access 25.53 MW of renewable wind and solar ...

Read more

28 Mar 2025 15:15

News

Board of Laurus Labs approves investment of Rs 83.30 cr in KRKA Pharma

The Board of Laurus Labs at its meeting held on 06 March 2025 has approved investment of a...

Read more

06 Mar 2025 19:44

News

Laurus Labs Ltd soars 3.43%, up for third straight session

Laurus Labs Ltd rose for a third straight session today. The stock is quoting at Rs 564.2,...

Read more

05 Mar 2025 13:06

SWOT Analysis Of Laurus Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Laurus Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Divis Laboratories Ltd and Laurus Labs Ltd

Which company has a larger market capitalization, Divis Laboratories Ltd or Laurus Labs Ltd?

Market cap of Divis Laboratories Ltd is 163,419 Cr while Market cap of Laurus Labs Ltd is 33,021 Cr

What are the key factors driving the stock performance of Divis Laboratories Ltd and Laurus Labs Ltd?

The stock performance of Divis Laboratories Ltd and Laurus Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Divis Laboratories Ltd and Laurus Labs Ltd?

As of May 7, 2025, the Divis Laboratories Ltd stock price is INR ₹6155.9. On the other hand, Laurus Labs Ltd stock price is INR ₹612.35.

How do dividend payouts of Divis Laboratories Ltd and Laurus Labs Ltd compare?

To compare the dividend payouts of Divis Laboratories Ltd and Laurus Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions